ANANDARAJ SUBRAMANIUM M.D. NPI 1194767657

NPI Details

Anandaraj Subramanium, M.D. is a family medicine in Mountain View, AR with 32 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. Anandaraj Subramanium, M.D. NPI is 1194767657. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1809 OZARKA COLLEGE DRIVE
MOUNTAIN VIEW, AR
ZIP 72560-198
Phone: (870) 269-7777
Fax: (870) 269-5055

The NPI 1194767657 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Hemoglobin a1c level (HCPCS:83036)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Urine microalbumin (protein) analysis (HCPCS:82044)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Initial hospital observation care per day, typically 50 minutes (HCPCS:99219)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Urinalysis, manual test (HCPCS:81002)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Hospital observation care on day of discharge (HCPCS:99217)
• Ultrasound study of arm and leg arteries (HCPCS:93922)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Blood test, clotting time (HCPCS:85610)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Follow-up observation care per day, typically 25 minutes (HCPCS:99225)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a (HCPCS:G0179)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring (HCPCS:M0243)
• Intravenous infusion, sotrovimab, includes infusion and post administration monitoring (HCPCS:M0247)
• Stool analysis for blood, by fecal hemoglobin determination by immunoassay (HCPCS:82274)
• Aspiration and/or injection of fluid from medium joint (HCPCS:20605)
• Removal of impacted ear wax (HCPCS:69210)
• Simple or single drainage of skin abscess (HCPCS:10060)
• Removal of noncancer skin growth of body, arms, or legs, 2.1-3.0 cm (HCPCS:11403)
• Removal of noncancer skin growth of body, arms, or legs, more than 4.0 cm (HCPCS:11406)
• Removal of noncancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm (HCPCS:11443)
• Electrocardiogram (ecg) 2-day continuous with review and report by health care professional (HCPCS:93224)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Removal of noncancer skin growth of body, arms, or legs, 3.1-4.0 cm (HCPCS:11404)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Imaging of retina with remote review by physician (HCPCS:92228)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 6/11/2006 and was last updated on 12/17/2013.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.